ArticleESMO open2026

Corrigendum to "A phase II study of intrapatient dose escalation of biweekly trifluridine/tipiracil plus bevacizumab for colorectal cancer (E-BiTS study)": [ESMO Open. Volume 10, Issue 9, (September 2025) 105571].

M Wakabayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.